BLACK FRIDAY 23–30 November: every kit at our 50+ kit price, any quantity. See the offer →
BLACK FRIDAY 23–30 November: every kit at our 50+ kit price, any quantity. See the offer →
BLACK FRIDAY 23–30 November: every kit at our 50+ kit price, any quantity. See the offer →
BLACK FRIDAY 23–30 November: every kit at our 50+ kit price, any quantity. See the offer →
A wholesale research peptide order should arrive with a lot number on every vial, a tracking record, and either the third-party report for that lot or a clear statement that testing is in progress. Marketing material, generic certificates without a lot number, and usage instructions are not documentation and should raise questions.
The label is the first document. It should state the compound, the fill in milligrams, the lot number, the CAS number where one exists, the storage temperature, and that the product is for research use only. Notary Peptides prints all of these on every vial.
A tracking number at dispatch, and the batch status for the lot: at Notary Peptides, if the third-party report has been issued it is supplied as a PDF, and if testing is still in progress that is stated as such. A report that does not quote the lot number on your vials does not describe your order.
Instructions for preparing or using the product on people or animals. In 2026 the US FDA issued warning letters to research-use-only sellers whose websites and accompanying materials showed intended human use, citing items such as preparation guides and calculators supplied alongside the product. Documentation that goes beyond identity, quantity, storage and test status changes what the product is being sold as. Notary Peptides supplies none of it.
Keep, per kit sold: lot number, customer and date. With that, any later question from a customer or any batch result can be traced in both directions.
A five-minute intake routine catches nearly everything. Match the lot number on the vials to the lot number on the batch documentation — an exact string match, not a similar one. Match the compounds and fills on the labels to the order confirmation. If a report accompanies the lot, confirm it quotes the same lot number; a report quoting a different lot describes different material. Record the lot numbers into the sales log before the kits go into storage. Any mismatch found at intake is a documentation question the supply team can fix while the facts are fresh; the same mismatch found months later, after kits have been sold, is a reconstruction project.
Because the paperwork around a product is evidence of what it is being sold as. The 2026 FDA warning letters to research-use sellers cited not the compounds themselves but the surrounding materials — preparation guides, calculators and instructions whose only use is administration — as showing intended human use. The lesson for a reseller cuts both ways. Documentation limited to identity, quantity, storage and test status supports the research-use framing; documentation that drifts beyond it undermines the framing for every party in the chain, whatever the label says. A supplier that declines to include usage material is not being unhelpful; it is keeping the product what the label says it is.
At Notary Peptides, the batch’s third-party report is shared against the lot number once issued; if testing is in progress, that is stated rather than substituted with a generic certificate.
Lot numbers are on the vials and the batch documentation; ask the supply team if you want them repeated on the invoice.
If it has been issued for that lot, yes, by quoting the lot number.
The batch status says testing is in progress, and the report follows once issued. A pending status stated plainly is worth more than a generic certificate supplied to fill the gap.
All Notary Peptides products are chemical reference materials supplied strictly for in-vitro laboratory research. Not for human or veterinary use. This guide describes commercial terms and documentation only.